Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum.
Ascaso JF, Fernández-Cruz A, González Santos P, Hernández Mijares A, Mangas Rojas A, Millán J, Felipe Pallardo L, Pedro-Botet J, Pérez-Jiménez F, Pía G, Pintó X, Plaza I, Rubiés-Prat J; HDL Forum. Ascaso JF, et al. Am J Cardiovasc Drugs. 2004;4(5):299-314. doi: 10.2165/00129784-200404050-00003. Am J Cardiovasc Drugs. 2004. PMID: 15449972 Review.
[The role of atherogenic dyslipidaemia in clinical practice guidelines].
Pedro-Botet J, Mantilla-Morató T, Díaz-Rodríguez Á, Brea-Hernando Á, González-Santos P, Hernández-Mijares A, Pintó X, Millán Núñez-Cortés J. Pedro-Botet J, et al. Among authors: gonzalez santos p. Clin Investig Arterioscler. 2016 Mar-Apr;28(2):65-70. doi: 10.1016/j.arteri.2015.12.004. Epub 2016 Mar 2. Clin Investig Arterioscler. 2016. PMID: 26949069 Spanish.
[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].
Millán J, Hernández-Mijares A, Ascaso JF, Blasco M, Brea A, Díaz Á, González-Santos P, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis. Millán J, et al. Among authors: gonzalez santos p. Clin Investig Arterioscler. 2016 Nov-Dec;28(6):265-270. doi: 10.1016/j.arteri.2016.05.002. Epub 2016 Sep 12. Clin Investig Arterioscler. 2016. PMID: 27633523 Spanish.
[Decalogue of clinical recommendations on atherogenic dyslipidemia].
Pedro-Botet J, Millán J, Brea Á, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Pintó X, Simó R. Pedro-Botet J, et al. Clin Investig Arterioscler. 2014 Jan-Feb;26(1):38-40. doi: 10.1016/j.arteri.2013.11.007. Epub 2013 Dec 21. Clin Investig Arterioscler. 2014. PMID: 24365580 Spanish. No abstract available.
Use of expert consensus to improve atherogenic dyslipidemia management.
Millán Núñez-Cortés J, Pedro-Botet J, Brea-Hernando Á, Díaz-Rodríguez Á, González-Santos P, Hernández-Mijares A, Mantilla-Morató T, Pintó-Sala X, Simó R. Millán Núñez-Cortés J, et al. Rev Esp Cardiol (Engl Ed). 2014 Jan;67(1):36-44. doi: 10.1016/j.rec.2013.06.011. Epub 2013 Nov 8. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774262
[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].
Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, González-Santos P, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X; en nombre del Foro de la Dislipemia Aterogénica. Brea A, et al. Among authors: gonzalez santos p. Clin Investig Arterioscler. 2016 Nov-Dec;28(6):295-301. doi: 10.1016/j.arteri.2016.06.001. Epub 2016 Sep 5. Clin Investig Arterioscler. 2016. PMID: 27609708 Spanish.
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.
Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis. Brea Á, et al. Among authors: gonzalez santos p. Clin Investig Arterioscler. 2017 Jul-Aug;29(4):185-200. doi: 10.1016/j.arteri.2016.06.002. Epub 2016 Sep 28. Clin Investig Arterioscler. 2017. PMID: 27692632 Review. English, Spanish.
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis. Brea Á, et al. Among authors: gonzalez santos p. Clin Investig Arterioscler. 2017 May-Jun;29(3):141-148. doi: 10.1016/j.arteri.2016.06.003. Epub 2016 Sep 28. Clin Investig Arterioscler. 2017. PMID: 27692633 Review. English, Spanish.
104 results